Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
alfuzosin sandoz 10 mg retardtabletten
sandoz pharmaceuticals ag - alfuzosini hydrochloridum - retardtabletten - alfuzosini hydrochloridum 10 mg, hypromellosum, oleum vegetabile hydrogenatum, calcii hydrogenophosphas dihydricus, povidonum k 30, silica colloidalis anhydrica, magnesii stearas, propylenglycolum, e 171, pro compresso obducto. - iperplasia prostatica benigna - synthetika
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
fuzocim 10 retardtabletten
acino pharma ag - alfuzosini hydrochloridum - retardtabletten - alfuzosini hydrochloridum 10 mg, hypromellosum, lactosum monohydricum 8 mg, povidonum k 25, magnesii stearas, pro compresso. - iperplasia prostatica benigna - synthetika
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
omix ocas 0.4 mg retardtabletten
astellas pharma ag - tamsulosinum - retardtabletten - tamsulosini hydrochloridum 400 µg corresp. tamsulosinum 367 µg, macrogolum 8000, magnesii stearas, macrogolum 7'000'000 cum e 321 et silica colloidalis hydrica, Überzug: hypromellosum, macrogolum 8000, e 172 (flavum), pro compresso obducto. - iperplasia prostatica benigna - synthetika
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
alfuzosine uno zentiva 10 mg retardtabletten
helvepharm ag - alfuzosini hydrochloridum - retardtabletten - alfuzosini hydrochloridum 10 mg, hypromellosum, ricini oleum hydrogenatum, ethylcellulosum, silica colloidalis hydrica, magnesii stearas, mannitolum, povidonum, cellulosum microcristallinum, ethanolum 96 per centum, aqua purificata, e 172 (flavum), pro compresso. - iperplasia prostatica benigna - synthetika
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
tamsulosin axapharm retardkapseln
axapharm ag - tamsulosini hydrochloridum - retardkapseln - tamsulosini hydrochloridum 0,4 mg, colore.: e 132, excipiens pro capsula. - iperplasia prostatica benigna - synthetika
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
tamsulosin-mepha retard depocaps
mepha pharma ag - tamsulosini hydrochloridum - depocaps - tamsulosini hydrochloridum 0,4 mg, colore.: e 132, excipiens pro capsula. - iperplasia prostatica benigna - synthetika
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
tamsulosin-mepha retard depocaps
mepha pharma ag - tamsulosini hydrochloridum - depocaps - tamsulosini hydrochloridum 0,4 mg, colore.: e 132, excipiens pro capsula. - iperplasia prostatica benigna - synthetika
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
tamsulosin mylan retardkapseln
mylan pharma gmbh - tamsulosinum - retardkapseln - tamsulosini hydrochloridum 0,4 mg corrisp. tamsulosinum 0.367 mg, cellulosum microcristallinum, acidi methacrylici e ethylis acrylatis polymerisati 1:1 dispersio 30 per cento con polysorbatum 80 e natrii laurilsulfas corrisp. sodio 7.28 µg, triethylis citras, talco, kapselhülle: gelatina, e 132, e 171, e 172 (rosso) e 172 (giallo) e 172 (nero) per la capsula. - iperplasia prostatica benigna - synthetika
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
alfuzosin axapharm retardtabletten
axapharm ag - alfuzosini hydrochloridum - retardtabletten - alfuzosini hydrochloridum 10 mg, excipiens pro compresso. - iperplasia prostatica benigna - synthetika
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
tamsulosin t sandoz retardtabletten
sandoz pharmaceuticals ag - tamsulosinum - retardtabletten - tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, hypromellosum, cellulosum microcristallinum, carbomerum, silica colloidalis anhydrica, magnesii stearas, e 172 (rubrum), pro compresso obducto. - iperplasia prostatica benigna - synthetika